- Home
- CLDI vs COSM Comparison
CLDI vs COSM Comparison
Compare CLDI & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- COSM
- Stock Information
- Founded
- CLDI 2014
- COSM 2009
- Country
- CLDI United States
- COSM United States
- Employees
- CLDI N/A
- COSM N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- COSM Other Pharmaceuticals
- Sector
- CLDI Health Care
- COSM Health Care
- Exchange
- CLDI Nasdaq
- COSM Nasdaq
- Market Cap
- CLDI 18.1M
- COSM 19.4M
- IPO Year
- CLDI N/A
- COSM 2013
- Fundamental
- Price
- CLDI $0.76
- COSM $0.77
- Analyst Decision
- CLDI Strong Buy
- COSM
- Analyst Count
- CLDI 3
- COSM 0
- Target Price
- CLDI $16.67
- COSM N/A
- AVG Volume (30 Days)
- CLDI 1.2M
- COSM 623.9K
- Earning Date
- CLDI 03-14-2025
- COSM 11-14-2024
- Dividend Yield
- CLDI N/A
- COSM N/A
- EPS Growth
- CLDI N/A
- COSM N/A
- EPS
- CLDI N/A
- COSM N/A
- Revenue
- CLDI N/A
- COSM $56,042,109.00
- Revenue This Year
- CLDI N/A
- COSM $4.53
- Revenue Next Year
- CLDI N/A
- COSM $25.00
- P/E Ratio
- CLDI N/A
- COSM N/A
- Revenue Growth
- CLDI N/A
- COSM 13.01
- 52 Week Low
- CLDI $0.69
- COSM $0.47
- 52 Week High
- CLDI $16.80
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- CLDI 29.25
- COSM 53.56
- Support Level
- CLDI $0.83
- COSM $0.51
- Resistance Level
- CLDI $0.94
- COSM $1.05
- Average True Range (ATR)
- CLDI 0.12
- COSM 0.11
- MACD
- CLDI -0.02
- COSM 0.02
- Stochastic Oscillator
- CLDI 9.85
- COSM 48.37
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.